Skip to main content
Erschienen in: European Radiology 12/2022

16.06.2022 | Hepatobiliary-Pancreas

CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study

verfasst von: Chen Yu Jiao, Hui Zhang, Gu Wei Ji, Qing Xu, Ming Lu, Biao Zhang, Yue Yang, Xue Hao Wang, Xiang Cheng Li

Erschienen in: European Radiology | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To establish prognostic nomograms based on CT imaging features for predicting the prognosis in patients with intrahepatic mass-forming cholangiocarcinoma (IMCC) before and after surgery.

Methods

Two models were established for overall survival (OS) prediction in a training set (179 IMCC patients underwent surgery at institution 1 from 2009 to 2019): imaging-based nomogram included imaging features and clinical characteristics acquired before surgery; postoperative nomogram included imaging-based score, equal to the linear predictor of the imaging-based nomogram, and pathological parameters. Both prognostic nomograms were validated in an independent external dataset (103 IMCC patients received surgical treatment at two independent institutions from 2009 to 2019). Predictive performance and discrimination were evaluated and compared with the common prognostic models.

Results

The imaging-based nomogram was developed according to preoperative serum carbohydrate antigen 19-9 and four imaging features including multiple nodules, arterial enhancement pattern, CT-reported lymph node (LN) metastasis, and capsular retraction; the postoperative nomogram was built based on the imaging-based score and three pathological parameters including tumor differentiation grade, capsular invasion, and LN status. Both nomograms presented improved prognostic performance and discrimination (concordance index, 0.770–0.812; integrated Brier score, 0.120–0.138) compared with the common prognostic models in the training and external validation datasets. Besides, the nomograms stratified IMCC patients into two risk strata for OS.

Conclusions

Nomograms based on CT imaging features can provide accurate individual survival prediction for IMCC patients before and after surgery, which may help to improve personalized treatment.

Key Points

• Imaging features including multiple nodules, arterial enhancement pattern, CT-reported LN metastasis, and capsular retraction were poor independent prognostic factors for IMCC patients.
• The imaging-based nomograms presented improved prognostic performance and discrimination compared with the common prognostic models.
• The nomograms can provide accurate individual survival prediction for IMCC patients before and after surgery.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX (2021) Biliary tract cancer. Lancet 30:428–444CrossRef Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX (2021) Biliary tract cancer. Lancet 30:428–444CrossRef
4.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefPubMed
5.
Zurück zum Zitat Aishima S, Oda Y (2015) Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci 22:94–100CrossRefPubMed Aishima S, Oda Y (2015) Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci 22:94–100CrossRefPubMed
6.
Zurück zum Zitat Nakanuma Y, Kakuda Y (2015) Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol 29:277–293CrossRefPubMed Nakanuma Y, Kakuda Y (2015) Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol 29:277–293CrossRefPubMed
8.
Zurück zum Zitat Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72:364–377CrossRefPubMed Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72:364–377CrossRefPubMed
9.
Zurück zum Zitat Tsilimigras DI, Hyer JM, Paredes AZ et al (2021) Tumor burden dictates prognosis among patients undergoing resection of intrahepatic cholangiocarcinoma: a tool to guide post-resection adjuvant chemotherapy? Ann Surg Oncol 28:1970–1978CrossRefPubMed Tsilimigras DI, Hyer JM, Paredes AZ et al (2021) Tumor burden dictates prognosis among patients undergoing resection of intrahepatic cholangiocarcinoma: a tool to guide post-resection adjuvant chemotherapy? Ann Surg Oncol 28:1970–1978CrossRefPubMed
10.
Zurück zum Zitat Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99CrossRefPubMed Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67:93–99CrossRefPubMed
11.
Zurück zum Zitat Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188–1195CrossRefPubMed Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188–1195CrossRefPubMed
12.
Zurück zum Zitat Hyder O, Marques H, Pulitano C et al (2014) A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg 149:432–438CrossRefPubMed Hyder O, Marques H, Pulitano C et al (2014) A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg 149:432–438CrossRefPubMed
13.
Zurück zum Zitat Raoof M, Dumitra S, Ituarte PHG et al (2017) Development and validation of a prognostic score for intrahepatic cholangiocarcinoma. JAMA Surg 152:e170117CrossRefPubMedPubMedCentral Raoof M, Dumitra S, Ituarte PHG et al (2017) Development and validation of a prognostic score for intrahepatic cholangiocarcinoma. JAMA Surg 152:e170117CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Jiang W, Zeng ZC, Tang ZY et al (2011) A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. Ann Oncol 22:1644–1652CrossRefPubMed Jiang W, Zeng ZC, Tang ZY et al (2011) A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. Ann Oncol 22:1644–1652CrossRefPubMed
15.
Zurück zum Zitat Koh J, Chung YE, Nahm JH et al (2016) Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol 26:407–416CrossRefPubMed Koh J, Chung YE, Nahm JH et al (2016) Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol 26:407–416CrossRefPubMed
16.
Zurück zum Zitat Kim SA, Lee JM, Lee KB et al (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology 260:148–157CrossRefPubMed Kim SA, Lee JM, Lee KB et al (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology 260:148–157CrossRefPubMed
17.
Zurück zum Zitat Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751–760CrossRefPubMed Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751–760CrossRefPubMed
18.
Zurück zum Zitat Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V (2021) Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol 34:408–416CrossRefPubMed Guedj N, Blaise L, Cauchy F, Albuquerque M, Soubrane O, Paradis V (2021) Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma. Mod Pathol 34:408–416CrossRefPubMed
19.
Zurück zum Zitat Høgdall D, Lewinska M, Andersen JB (2018) Desmoplastic tumor microenvironment and immunotherapy in cholangiocarcinoma. Trends Cancer 4:239–255CrossRefPubMed Høgdall D, Lewinska M, Andersen JB (2018) Desmoplastic tumor microenvironment and immunotherapy in cholangiocarcinoma. Trends Cancer 4:239–255CrossRefPubMed
20.
Zurück zum Zitat Gentilini A, Pastore M, Marra F et al (2018) The role of stroma in cholangiocarcinoma: the intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium. Int J Mol Sci 19:2885CrossRefPubMedPubMedCentral Gentilini A, Pastore M, Marra F et al (2018) The role of stroma in cholangiocarcinoma: the intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium. Int J Mol Sci 19:2885CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Gentilini A, Pastore M, Marra F, Raggi C (2017) Tumor reactive stroma in cholangiocarcinoma: the fuel behind cancer aggressiveness. World J Hepatol 9:455–468CrossRef Gentilini A, Pastore M, Marra F, Raggi C (2017) Tumor reactive stroma in cholangiocarcinoma: the fuel behind cancer aggressiveness. World J Hepatol 9:455–468CrossRef
22.
Zurück zum Zitat Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603–W611CrossRefPubMed Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603–W611CrossRefPubMed
23.
Zurück zum Zitat Fujita N, Asayama Y, Nishie A et al (2017) Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings. Eur Radiol 27:498–506CrossRefPubMed Fujita N, Asayama Y, Nishie A et al (2017) Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings. Eur Radiol 27:498–506CrossRefPubMed
25.
Zurück zum Zitat Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98CrossRefPubMed Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98CrossRefPubMed
26.
Zurück zum Zitat Panick CEP, Ward RD, Coppa C, Liu PS (2019) Hepatic capsular retraction: an updated MR imaging review. Eur J Radiol 113:15–23CrossRefPubMed Panick CEP, Ward RD, Coppa C, Liu PS (2019) Hepatic capsular retraction: an updated MR imaging review. Eur J Radiol 113:15–23CrossRefPubMed
27.
Zurück zum Zitat Min JH, Kim YK, Choi SY et al (2019) Intrahepatic mass-forming cholangiocarcinoma: arterial enhancement patterns at MRI and prognosis. Radiology 290:691–699CrossRefPubMed Min JH, Kim YK, Choi SY et al (2019) Intrahepatic mass-forming cholangiocarcinoma: arterial enhancement patterns at MRI and prognosis. Radiology 290:691–699CrossRefPubMed
28.
Zurück zum Zitat He C, Zhang Y, Song Y et al (2018) Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma. J Cancer 9:3117–3128CrossRefPubMedPubMedCentral He C, Zhang Y, Song Y et al (2018) Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma. J Cancer 9:3117–3128CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Miwa S, Miyagawa S, Kobayashi A et al (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41:893–900CrossRefPubMed Miwa S, Miyagawa S, Kobayashi A et al (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41:893–900CrossRefPubMed
30.
Zurück zum Zitat Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149:565–574CrossRefPubMed Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149:565–574CrossRefPubMed
31.
Zurück zum Zitat Addeo P, Jedidi I, Locicero A et al (2019) prognostic impact of tumor multinodularity in intrahepatic cholangiocarcinoma. J Gastrointest Surg 23:1801–1809CrossRefPubMed Addeo P, Jedidi I, Locicero A et al (2019) prognostic impact of tumor multinodularity in intrahepatic cholangiocarcinoma. J Gastrointest Surg 23:1801–1809CrossRefPubMed
32.
Zurück zum Zitat Conci S, Ruzzenente A, Viganò L et al (2018) Patterns of distribution of hepatic nodules (single, satellites or multifocal) in intrahepatic cholangiocarcinoma: prognostic impact after surgery. Ann Surg Oncol 25:3719–3727CrossRefPubMed Conci S, Ruzzenente A, Viganò L et al (2018) Patterns of distribution of hepatic nodules (single, satellites or multifocal) in intrahepatic cholangiocarcinoma: prognostic impact after surgery. Ann Surg Oncol 25:3719–3727CrossRefPubMed
34.
Zurück zum Zitat Shroff RT, Kennedy EB, Bachini M et al (2019) Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol 37:1015–1027CrossRefPubMed Shroff RT, Kennedy EB, Bachini M et al (2019) Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline. J Clin Oncol 37:1015–1027CrossRefPubMed
35.
Zurück zum Zitat Mazzaferro V, El-Rayes BF, Droz Dit Busset M et al (2019) Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. Br J Cancer 120:165–171CrossRefPubMed Mazzaferro V, El-Rayes BF, Droz Dit Busset M et al (2019) Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. Br J Cancer 120:165–171CrossRefPubMed
36.
Zurück zum Zitat Kim RD, Chung V, Alese OB et al (2020) A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer. JAMA Oncol 6:888–894CrossRefPubMed Kim RD, Chung V, Alese OB et al (2020) A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer. JAMA Oncol 6:888–894CrossRefPubMed
Metadaten
Titel
CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study
verfasst von
Chen Yu Jiao
Hui Zhang
Gu Wei Ji
Qing Xu
Ming Lu
Biao Zhang
Yue Yang
Xue Hao Wang
Xiang Cheng Li
Publikationsdatum
16.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08914-0

Weitere Artikel der Ausgabe 12/2022

European Radiology 12/2022 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.